Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page
- Check2 days agoChange DetectedA new revision label v3.5.3 was added, replacing the previous v3.5.2 in the page header. This indicates an internal update to the page version without altering visible content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now lists the Vienna location with the more specific label “State of Vienna, Vienna, Austria.” The displayed site revision/version number has also been updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a publication citation for MAESTRO-NASH (Schattenberg et al., J Hepatol) and removed MedlinePlus Genetics as a related topic.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the Study Details page.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded the related topic 'Non-alcoholic fatty liver disease' to the study page and updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved related topics: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' from the related topics section.SummaryDifference0.0%

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.